Richard Francis Riedel, MD

Associate Professor of Medicine
Member of the Duke Cancer Institute
Campus mail Dept of Medicine, 25179 Morris Bldg, Durham, NC 27710
Phone (919) 681-8031
Email address richard.riedel@duke.edu

Novel therapies for soft tissue and bone sarcomas

In Their Words

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 2005 - 2007
  • Fellow in Hematology-Oncology, Medicine, Duke University, 2003 - 2004
  • Resident in Medicine, Medicine, Duke University, 2000 - 2003
  • M.D., Thomas Jefferson University, 2000

Grants

Publications

Avutu, Viswatej, Aaron R. Weiss, Damon R. Reed, Safia K. Ahmed, Wendy A. Allen-Rhoades, Yen-Lin E. Chen, Lara E. Davis, et al. “Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321.” J Adolesc Young Adult Oncol 11, no. 3 (June 2022): 328–32. https://doi.org/10.1089/jayao.2021.0103.

PMID
34515544
Full Text

Chawla, Sant P., Brian A. Van Tine, Seth M. Pollack, Kristen N. Ganjoo, Anthony D. Elias, Richard F. Riedel, Steven Attia, et al. “Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1.” J Clin Oncol 40, no. 12 (April 20, 2022): 1291–1300. https://doi.org/10.1200/JCO.20.03452.

PMID
34260265
Full Text

Gounder, Mrinal M., Albiruni Abdul Razak, Neeta Somaiah, Sant Chawla, Javier Martin-Broto, Giovanni Grignani, Scott M. Schuetze, et al. “Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.” J Clin Oncol, April 8, 2022, JCO2101829. https://doi.org/10.1200/JCO.21.01829.

PMID
35394800
Full Text

Meyer, Mathias, Peter Hohenberger, Daniel Overhoff, Anna Bartsch, Thomas Henzler, Holger Haubenreisser, James Ronald, et al. “Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT Criteria.” Ajr Am J Roentgenol 218, no. 4 (April 2022): 659–69. https://doi.org/10.2214/AJR.21.26636.

PMID
34668385
Full Text

Wagner, Andrew J., Vinod Ravi, Richard F. Riedel, Kristen Ganjoo, Brian A. Van Tine, Rashmi Chugh, Lee Cranmer, et al. “nab-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors.” J Clin Oncol 39, no. 33 (November 20, 2021): 3660–70. https://doi.org/10.1200/JCO.21.01728.

PMID
34637337
Full Text

Gounder, Mrinal, Albiruni R. Abdul Razak, Adrienne M. Gilligan, Hoyee Leong, Xiwen Ma, Neeta Somaiah, Sant P. Chawla, et al. “Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma.” Future Oncol 17, no. 22 (August 2021): 2923–39. https://doi.org/10.2217/fon-2021-0284.

PMID
33855868
Full Text

Lagos, Galina, Roman Groisberg, Don S. Dizon, Andrew Elliott, Tabitha Copeland, Andreas Seeber, Geoffrey Thomas Gibney, et al. “Large scale multiomic analysis suggests mechanisms of resistance to immunotherapy in leiomyosarcoma.” In Journal of Clinical Oncology, 39:11512–11512. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.15_suppl.11512.

Full Text

Copeland, Tabitha, Roman Groisberg, Don S. Dizon, Andrew Elliott, Galina Lagos, Andreas Seeber, Margaret von Mehren, et al. “Multiomic analysis to reveal distinct molecular profiles of uterine and nonuterine leiomyosarcoma.” In Journal of Clinical Oncology, 39:11555–11555. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.15_suppl.11555.

Full Text

Naqash, Abdul Rafeh, Geraldine Helen O’Sullivan Coyne, Nancy Moore, Elad Sharon, Naoko Takebe, Kristin K. Fino, Katherine V. Ferry-Galow, et al. “Phase II study of atezolizumab in advanced alveolar soft part sarcoma (ASPS).” In Journal of Clinical Oncology, 39:11519–11519. American Society of Clinical Oncology (ASCO), 2021. https://doi.org/10.1200/jco.2021.39.15_suppl.11519.

Full Text

Pages